Advantest pulled its 10,000-tester capacity target to end-2027, a year ahead of plan; the stock fell 7.4%

The ramp now has a date

Advantest▲+2.08% — Advantest, up 2.08 percent today, the Japanese company whose machines test AI accelerators and memory chips before they ship, has put a date on its factory buildout: annual capacity of about 10,000 system-on-chip, or SoC, testers by the end of 2027, roughly a year earlier than its previous schedule, according to a November 13 note from brokerage Longbridge↗ citing Advantest executives at an investor event ¹.

The script of the fireside chat went up on Advantest's investor-relations page on November 12 ⁵. Demand is not subtle. On the October 28 earnings call↗, Group CEO Douglas Lefever said GPU and custom-ASIC orders are "running very hot" and that CPU demand is "probably the biggest factor" behind the raised outlook ⁴.

The raise the market sold

The date extends an October 28 forecast raise↗ that investors have already traded against ². First-half net sales rose 60.5 percent to ¥845.2 billion and net income jumped 116.8 percent to ¥368.1 billion; the full-year guide rose to ¥1,863.0 billion of sales and ¥967.0 billion of operating income, from ¥1,714.0 billion and ¥846.0 billion in July ². The stock still slipped 7.41 percent on November 12 ². Part of the discount is earnings quality: ¥54.2 billion of the half-year profit was valuation gains on financial instruments, while the core test-system business grew 61.2 percent ².

The customers kept buying

ChipMOS▼−2.80% — ChipMOS, down 2.80 percent today, a Taiwan chip assembly and test house, filed the physical receipt: NT$805.5 million of machinery bought from Advantest Taiwan between April 8 and November 10, a purchase window that runs straight through the stock's slide ³⁶, as The Inference reported on November 10↗.

Its third quarter shows what the machines are for: record revenue of NT$8,400.8 million, net profit of NT$1,323.3 million, 3.8 times a year earlier, gross margin up to 21.7 percent from 12.4 percent, and utilization of 70 to 77 percent, from 57 to 70 percent ³⁶.

October revenue rose 30.9 percent ⁷, and nine-month profit of NT$2.72 billion reversed a year-earlier loss ⁸. Teradyne▼−8.17% — Teradyne, down 8.17 percent today, Advantest's US rival, matched the picture: third-quarter revenue up 70 percent to $1,306 million↗ on record memory-test sales ⁹.

What breaks the schedule

Advantest itself names component availability and supply-chain resilience as the priorities that decide whether orders become shipments, and it expects a record tester market in calendar 2026 ¹². Rising depreciation on ChipMOS's newly installed lines is the same constraint from the customer side, pressing on that 21.7 percent gross margin ³. The orders say customers believe the test bottleneck is real; the share price, up just 2.08 percent in Tokyo on November 13 ⁵, says investors do not yet believe the schedule. Next readings: Advantest's semi-annual securities report, filed November 13 ², and ChipMOS's November and December revenue prints ³.